SEC Ends Bribery Probe Into Chinese Vaccine Co.
The U.S. Securities and Exchange Commission has dropped its investigation into potential violations of the Foreign Corrupt Practices Act by Chinese vaccine maker Sinovac Biotech Ltd., the company announced on Monday....To view the full article, register now.
Already a subscriber? Click here to view full article